Sacral neuromodulation: long-term outcome and quality of life in patients with faecal incontinence
Article first published online: 20 SEP 2011
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland
Volume 13, Issue 10, pages 1162–1166, October 2011
How to Cite
Uludağ, Ö., Melenhorst, J., Koch, S. M. P., van Gemert, W. G., Dejong, C. H. C. and Baeten, C. G. M. I. (2011), Sacral neuromodulation: long-term outcome and quality of life in patients with faecal incontinence. Colorectal Disease, 13: 1162–1166. doi: 10.1111/j.1463-1318.2010.02447.x
- Issue published online: 20 SEP 2011
- Article first published online: 20 SEP 2011
- Accepted manuscript online: 19 OCT 2010 04:41AM EST
- Received 26 April 2010; accepted 3 September 2010; Accepted Article online 19 October 2010
- Quality of life;
- sacral neuromodulation;
- sacral neurostimulation;
- faecal incontinence
Aim Since 1994 sacral neuromodulation (SNM) has increasingly been used for the treatment of faecal incontinence, but no long-term data in a large group of patients have so far been published. We report long-term outcome and quality of life in the first 50 patients treated by permanent SNM for faecal incontinence.
Method We began to use SNM in 2000. Data from the first 50 patients with faecal incontinence who underwent permanent SNM are presented. Efficacy was assessed using a bowel diary and the Quality of Life score was assessed by the Faecal Incontinence Quality of Life questionnaire (FIQOL) and the standard short form health survey questionnaire (SF-36).
Results Over a median follow up of 7.1 (5.6–8.7) years, forty-two (84%) patients had an improvement in continence of over 50%. Median incontinent episodes and days of incontinence per week decreased significantly during follow up (P < 0.002). Improvement was seen in all four categories of the FIQOL scale and in some domains of the SF-36 QOL questionnaire. There were no statistically significant changes in the median resting and squeeze anal canal pressures.
Conclusion Initial improvement in continence with SNM was sustained in the majority of patients, with an overall success rate of 80% after a permanent implant at 7 years.